Surface Oncology, Inc. Quarterly Return On Equity in % from Q3 2018 to Q2 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Surface Oncology, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2018 to Q2 2023.
  • Surface Oncology, Inc. Return On Equity for the quarter ending June 30, 2023 was -112 %, a 132% decline year-over-year.
  • Surface Oncology, Inc. annual Return On Equity for 2022 was -53.1 %, a 5.73% increase from 2021.
  • Surface Oncology, Inc. annual Return On Equity for 2021 was -56.3 %, a 200% decline from 2020.
  • Surface Oncology, Inc. annual Return On Equity for 2020 was 56.4 %.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q2 2023 -112 -63.5 -132% Apr 1, 2023 Jun 30, 2023
Q1 2023 -87.8 -46.2 -111% Jan 1, 2023 Mar 31, 2023
Q4 2022 -53.1 +3.23 +5.73% Oct 1, 2022 Dec 31, 2022
Q3 2022 -52.6 -61.3 -705% Jul 1, 2022 Sep 30, 2022
Q2 2022 -48.2 -60.6 -488% Apr 1, 2022 Jun 30, 2022
Q1 2022 -41.6 -58.6 -345% Jan 1, 2022 Mar 31, 2022
Q4 2021 -56.3 -113 -200% Oct 1, 2021 Dec 31, 2021
Q3 2021 8.69 +38.5 Jul 1, 2021 Sep 30, 2021
Q2 2021 12.4 +45.3 Apr 1, 2021 Jun 30, 2021
Q1 2021 17 +55.5 Jan 1, 2021 Mar 31, 2021
Q4 2020 56.4 +127 Oct 1, 2020 Dec 31, 2020
Q3 2020 -29.8 +19.1 +39.1% Jul 1, 2020 Sep 30, 2020
Q2 2020 -32.9 +11.7 +26.3% Apr 1, 2020 Jun 30, 2020
Q1 2020 -38.4 +0.52 +1.34% Jan 1, 2020 Mar 31, 2020
Q4 2019 -70.6 -62.1 -729% Oct 1, 2019 Dec 31, 2019
Q3 2019 -48.9 +1.62 +3.21% Jul 1, 2019 Sep 30, 2019
Q2 2019 -44.6 Apr 1, 2019 Jun 30, 2019
Q1 2019 -39 Jan 1, 2019 Mar 31, 2019
Q4 2018 -8.52 Oct 1, 2018 Dec 31, 2018
Q3 2018 -50.5 Jul 1, 2018 Sep 30, 2018
* An asterisk sign (*) next to the value indicates that the value is likely invalid.